Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Radiosensitizers: rationale and potential

J M Brown

    Cancer Treatment Reports
    |January 1, 1981
    PubMed
    Summary

    New radiosensitizers, like SR-2508, show promise in enhancing radiation and chemotherapy for hypoxic tumors. These agents offer improved efficacy with reduced neurotoxicity compared to older drugs, potentially improving cancer treatment outcomes.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Nitric oxide synthase is not involved in cardiac contractile dysfunction in a rat model of endotoxemia without shock.

    Shock (Augusta, Ga.)·1997
    Same author

    A comparison of critical thinking abilities between accelerated and traditional baccalaureate nursing students.

    The Journal of nursing education·1997
    Same author

    Samuel Eugene Harmon (1871-1935).

    Journal of the South Carolina Medical Association (1975)·1997
    Same author

    Modification of the antitumor activity of chemotherapeutic drugs by the hypoxic cytotoxic agent tirapazamine.

    Cancer chemotherapy and pharmacology·1997
    Same author

    Three-dimensional structures of gonadotropins.

    Molecular and cellular endocrinology·1996
    Same author

    Evaluation of monoclonal antibodies for generic detection of flaviviruses by ELISA.

    Journal of virological methods·1996

    Area of Science:

    • Oncology
    • Radiation Oncology
    • Medical Chemistry

    Background:

    • Hypoxic cells in tumors are resistant to radiation and chemotherapy.
    • Misonidazole, a hypoxic cell radiosensitizer, is limited by neurotoxicity in clinical use.
    • Developing radiosensitizers with reduced toxicity is crucial for effective cancer therapy.

    Purpose of the Study:

    • To review the development of hypoxic cell radiosensitizers.
    • To introduce a novel radiosensitizer, SR-2508, with improved toxicity profile.
    • To explore the potential of radiosensitizers in combination with chemotherapy and as cytotoxic agents.

    Main Methods:

    • Review of existing literature on hypoxic radiosensitizers.
    • Synthesis and preclinical evaluation of novel radiosensitizing agents.
    • Assessment of radiosensitizing efficiency and toxicity of SR-2508.

    Main Results:

    • Misonidazole demonstrates radiosensitizing efficacy but is limited by dose-dependent neurotoxicity.
    • SR-2508 exhibits comparable radiosensitizing efficiency to misonidazole.
    • SR-2508 shows significantly reduced toxicity (4-10 times less) compared to misonidazole.

    Conclusions:

    • SR-2508 represents a promising new agent for sensitizing hypoxic tumor cells to radiation.
    • Radiosensitizers can potentially enhance chemotherapy efficacy and act as tumor-specific cytotoxic agents.
    • Further research into SR-2508 and similar agents could lead to improved cancer treatment strategies.

    Related Experiment Videos